Spotfade Dark Spot Wand

Manufacturer
Guthy-Renker LLC
Effective date
2020-01-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 23:42:07

Label at a glance#

ProductSpotfade Dark Spot Wand
Active ingredientHYDROQUINONE
Label structure9 sections

Dosage and administration

Adults: apply a small amount as thin layer on the affected area twice daily. Or use as directed by a doctor. If no improvement is seen after 3 months of treatment use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Fact Label

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone 2%

Purpose

OTC - PURPOSE SECTION

INDICATIONS & USAGE SECTION

Lightens dark spots

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

  • do not use on damaged or broken skin.

OTC - WHEN USING SECTION

When using this product

  • when using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor

  • if rash occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

  • if swallowed, get medical help or contact a Poison Control Center right away.

Sunburn Alert

SPL UNCLASSIFIED SECTION

These products contain alpha hydroxy acids (AHAs) that may increase your skins sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using these products and for a week afterwards.

SPL UNCLASSIFIED SECTION

Children under 12 years of age: do not use unless directed by a doctor.

Directions

DOSAGE & ADMINISTRATION SECTION

SPL UNCLASSIFIED SECTION

Adults: apply a small amount as thin layer on the affected area twice daily. Or use as directed by a doctor. If no improvement is seen after 3 months of treatment use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Alcohol Denat., Glycerin, Olive Oil Glycerth 8 Esters, Niacinamide, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Hexylresorcinol, Pentylene Glycol, Palmaria Palmata Extract, Sodium Sulfite, BHA, Retinol, Hexylene Glycol, Ethylhexylglycerin, Caprylyl Glycol, Maltodextrin, Denatonium Benzoate, t-Butyl Alcohol, Glycolic Acid, Polysorbate 80, Sorbitan Oleate, Disodium EDTA, Sodium Metabisulfite, Phenoxyethanol.

Questions or comments?

OTC - QUESTIONS SECTION

Within US 1-888-557-8164

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY THE BODY FIRM, LLC,
EL SEGUNDO, CA 90245

PRINCIPAL DISPLAY PANEL - 60 mL Tube Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BODY FIRM®

Spot Fade®

Dark Spot
Correcting Wand
with 2% Hydroquinone

WITH TRULIGHT™
TECHNOLOGY

NIGHT

60mL | 2 FL.OZ.

Principal Display Panel - 60 mL Tube Label
Principal Display Panel - 60 mL Tube Label

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70605-03770605-037-95, 70605-037-22

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0c283f78-ad46-4ba9-9e8f-17389625cfdc3d424405-5d05-429d-a7eb-8f3ddc341e492022-04-22WarningsExact identifier
spl set id: 3d424405-5d05-429d-a7eb-8f3ddc341e49

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.